cyclobenzaprine and Astrocytoma, Grade IV

cyclobenzaprine has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Faujdar, C; Liou, JP; Malik, B; Nepali, K; Sharma, R; Sharma, S; Thakur, A1
Aydemir, I; Mete, M; Sönmez, PK; Tuglu, MI; Ünsal, ÜÜ1

Reviews

1 review(s) available for cyclobenzaprine and Astrocytoma, Grade IV

ArticleYear
Glioblastoma: Current Status, Emerging Targets, and Recent Advances.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Antineoplastic Agents; Brain Neoplasms; Drug Discovery; Glioblastoma; Humans

2022

Other Studies

1 other study(ies) available for cyclobenzaprine and Astrocytoma, Grade IV

ArticleYear
Punicic Acid Inhibits Glioblastoma Migration and Proliferation via the PI3K/AKT1/mTOR Signaling Pathway.
    Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:9

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Linolenic Acids; Molecular Structure; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; TOR Serine-Threonine Kinases

2019